Showing 61 companies
Innovation Endeavors is an early-stage venture capital firm that invests in mission-driven founders, transformational technologies, and emergent ecosystems. The firm’s central investment thesis, the Super Evolution, combines data, leading-edge computation, and advanced engineering to transform a range of industries including agriculture, supply chain, the life sciences, transportation and more. Its investments include AlphaSense, Astra, Color, Blue River Technology, Eikon Therapeutics, Fabric, Formlabs, Freenome, Planet, Rebellion, Replica, SoFi, Uber, Upstart, Vicarious Surgical, and more. For more information, visit www.InnovationEndeavors.com.
At Afresh, we’re solving the big problems around food waste and the fresh food supply chain--focusing first on grocery. We use cutting-edge AI (we’ve been published in ICML!) combined with thoughtful design to enhance decision-making and optimize store workflows. The results are powerful: in live deployments in grocery stores, we have demonstrated the potential to double profits and reduce food waste by 50%+!
At Atom Computing, we’re our customers’ biggest fans on the journey of discovery. That’s why we’re obsessed with creating the world’s most scalable and reliable quantum computers—giving them the power to develop breakthroughs that change the world.
Authomize continuously monitors the organizations' identities, access privileges, assets, and activities, to secure all apps and cloud services. We seamlessly connect to organizations' apps and cloud services, collects all relevant information to graph's data-lake to help organizations' security teams achieve Zero Trust. Authomize provides organizations with comprehensive observability, actionable insights, and remediation automation, enabling adherence to security and compliance requirements.
Beamr is a global video software technology leader in H.264 and HEVC encoding and optimization solutions. The company was founded in 2009 by a team of leading image science experts and is backed by Verizon, Disruptive, and Eric Schmidt's fund, Innovation Endeavors. Beamr has more than 80 employees located in Palo Alto California, Tel Aviv Israel, and St. Petersburg Russia.
BigHat Biosciences is a developer of an AI-guided protein therapeutic platform used to integrate antibody characterization lab with machine learning technologies to engineer molecules with more complex functions and better biophysical properties. The company is applying these design capabilities to develop new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.
Bolt is a materials company that invents and scales materials that put the planet on a path towards a better future. Biofabricated silk fibers MicrosilkTM - based on proteins found in nature, produced using Bolt Threads proprietary technology and revolutionary bioengineering concepts. Next-generation of performance fibers, fabrics and luxury products that represent cutting-edge technology in science, while raising the bar for quality, performance, and design.
We believe in the power of technology to transform the way we build. It is our mission to improve the quality and affordability of the places where we live, work, sleep, and play, while simultaneously improving the working conditions of the people who build these spaces. We deliver unrivaled quality, speed, and predictability by putting robots in the hands of skilled workers. Through our novel approach, we have reinvented drywall finishing to give your projects better outcomes. Canvas is on a mission to improve the quality and affordability of the places where we live, work, sleep, and play, while simultaneously improving the working conditions of the people who build these spaces. We're just at the beginning, and looking for extraordinary people who sit at the intersection of 'high-performing' and 'empathic' to make it happen.
Character Biosciences (formerly Clover Therapeutics) is a precision medicine platform that is unlocking the patterns of age-related diseases in people of diverse backgrounds. Our mission is to use human genetics to understand what drives diseases so we can discover targeted therapies to more effectively treat patients - many of whom lack any treatment options today. Character partners with patients, providers, payers, and scientists to create deeply-phenotyped patient cohorts to enable clinical genomic research. Our approach integrates genomics, longitudinal clinical and imaging data, machine learning, and novel experimental approaches to identify the molecular drivers of disease progression and develop innovative targeted medicines.
CipherMode is a new data utilization and sharing platform which preserves the confidentiality of data during the entire data lifecycle including the computation itself. Aside from higher security, enterprises will be able to seamlessly leverage their data across different organizations and/or jurisdictions without violating any privacy regulations and incurring any data breach risk. In addition, CipherMode allows secure collaboration between multiple enterprises. Applications range anywhere from co-marketing to drug discovery to fraud detection. CipherMode is a cryptographic software-only solution that, unlike other privacy-enhancing technologies, e.g., trusted execution environments and differential privacy, provides provable security guarantees. Compared to Homomorphic Encryption, CipherMode is between two to three orders of magnitude faster. The technology is based on more than seven years of academic research. CipherMode’s team consists of several world-leading experts in secure computation.